test-sandeep

Study Title: Pulmonary rehabilitation delivered in low resource settings for people with chronic respiratory disease: a 3-arm assessor-blind randomised implementation trial

Status: Ongoing

Study Title: A Phase 3, randomised, double-blind, placebo-controlled, event-driven study to demonstrate the efficacy and safety of Milvexian, an Oral Factor XIa Inhibitor, after a recent acute coronary syndrome. (LIBREXIA-ACS)

Duration: 3 Years 6 Months

Status: Ongoing

Study Title: “A Phase 3, randomised, double-blind, double-dummy, parallel group, active controlled study to evaluate the efficacy and safety of Milvexian, an Oral Factor Xla Inhibitor, versus Apixaban in participants with Atrial Fibrillation (LIBREXIA-AF)”

Duration: 3 Years

Status: Ongoing

Study Title: “HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation (EX6018-4915)”

Duration: 4 Years

Status: Ongoing

Study Title: A multicentre, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction ≥ 40% (LVEF ≥ 40%)

Duration: 4 Years

Status: Closed

Study Title: International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)

Duration: 4 Years

Status: Closed

Study Title: International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)

Duration: 4 Years

Status: Completed

Study Title: A multicentre, randomised, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)

Duration: 2 Years

Status: Ongoing

Study Title: A multicentre, single-arm, open label trial to evaluate efficacy and safety of oral, twice daily LNP023 in adult aHUS patients who are naive to complement inhibitor therapy

Duration: 2 Years

Status: Ongoing

Study Title: A multicentric, randomised, prospective, double blind, parallel group, comparative, active controlled, phase III clinical study to evaluate the efficacy, safety and tolerability of Fixed Dose Combination of Dapagliflozin 10 mg and Telmisartan 80 mg versus concurrent use Dapagliflozin 10mg tablets and Telmisartan 80mg tablets in patients with chronic kidney disease.

Duration: 6 Months

Status: Closed

Study Title: Catalytic iron and hepcidin in patients with COVID-19 and their association with adverse outcomes.

Duration: 1 Year

Status: Closed

Study Title: Catalytic iron and hepcidin in patients with COVID-19 and their association with adverse outcomes.

Duration: 1 Year

Status: Closed

Study Title: A multicentre, single-arm, open label trial to evaluate efficacy and safety of oral, twice daily LNP023 in adult aHUS patients who are naive to complement inhibitor therapy

Duration: 2 Years

Status: Ongoing

Project Title: Clinical profile and short-term outcome of children with atypical haemolytic uremic syndrome

Duration: 3 Months

Status: Closed

Study Title: Follow-up of children born in a B12-multi micronutrient supplementation primordial trial (PRIYA) to reduce diabesity risk and improve neurocognitive performance

Duration: 1 Year

Status: Ongoing

Study Title: Study of causal mechanisms of early life determinants of adiposity: Analysis in a longitudinal study

Duration: 3 Years

Status: Ongoing

Study Title: A type–II Hybrid effectiveness – Implementation trial of community health workers to improve screening for postpartum diabetes in urban slums of India

Duration: 5 Years

Status: Ongoing

Study Title: Maharashtra Anaemia Study Phase 3 (MAS3): Longitudinal study of nutritional, economic, and environmental impacts on anaemia, physical and cognitive development in Indian children from birth to age 18 years, nested within ‘The Pune Maternal Nutrition Study’ (PMNS)

Duration: 1 Year

Status: Closed

Study Title: Molecular basis of nutritional foetal programming of ‘diabesity’ - Pune Rural Intervention in Young Adolescents (PRIYA) trial

Duration: 5 Years

Status: Closed

Study Title: Molecular basis of nutritional foetal programming of ‘diabesity’ - Pune Rural Intervention in Young Adolescents (PRIYA) trial.

Duration: 5 Years

Status: Closed

Study Title: Maharashtra Anaemia Study Phase 3 (MAS3): Longitudinal study of nutritional, economic, and environmental impacts on anaemia, physical and cognitive development in Indian children from birth to age 18 years, nested within ‘The Pune Maternal Nutrition Study’ (PMNS)

Duration: 1 Year

Status: Closed

Study Title: Persistence of immunogenicity of a single dose of Live Attenuated Hepatitis A Vaccine: A Follow-up Study 20 Years after vaccination

Duration: 6 Months

Status: Ongoing

Study Title: Risk factor, antibiotic sensitivity & outcome of culture – proven neonatal sepsis in intensive care unit: A 2 years retrospective study.

Duration: 2 Years

Status: Closed

Study Title: Foetal Movement Awareness in Pregnancy – Utility, Compliance and Outcomes in Pregnancy - Pilot Study

Status: Completed

Study Title: Exploring remote treatment strategy for persons with pedohebephilia in India

Duration: 10 Months

Status: Ongoing

Study Title: PATH India: Exploring Paedophilia - Access/Attitudes, Treatment, and Help-seeking in India.

Duration: 2 Years

Status: 2 Years

Study Title: The impact of the COVID-19 Pandemic on Well-Being, Stress, and Resilience of Adolescents and Caregivers in South Asia

Duration: 6 Months

Status: Ongoing

Study Title: Feasibility of expansion of clinical services and public health action to prevent & respond to sexual violence against children (Project with Charite, Berlin)

Duration: 1 Year

Status: Closed

Study Title: Program for Primary Prevention of Sexual Violence with a focus on treatment for persons with paedophilia (Project with Charite, Berlin)

Duration: 6 Months

Status: Closed

Study Title: Multinational field trial of CFI

Duration: 6 Months

Status: completed

Study Title: Sociocultural framework for comprehensive case formulation of sexually gender diverse (LGBTIQI) Individuals

Duration: 1 Year 1 Month

Status: Ongoing

Study Title: A prospective, randomised, double blind, multicentric, parallel group Phase-III clinical study to evaluate the efficacy, safety, and immunogenicity of BP01 (Bevacizumab) versus EU approved Avastin® along with chemotherapy XELOX in metastatic colorectal cancer patients.

Duration: 2 Years

Status: Ongoing

Study Title: A prospective, multicentric, single arm, Open label, Phase IV Clinical study to evaluate safety and efficacy of DenosuRelTM containing Denosumab manufactured by Reliance Life sciences Pvt. Ltd. India for prevention of skeletal related events in patients with bone metastases from solid tumours. (RLS/PMS/2021/01)

Duration: 2 Years

Status: Ongoing

Study Title: Prospective, multi-centre, randomized, open-label, two arm, parallel group, active-control, comparative clinical study to evaluate efficacy, safety and pharmacokinetics of R-TPR-023/ AvastinTM intravenously in patients with Metastatic colorectal cancer”

Duration: 2 Years

Status: Closed

Study Title: A multicentre, open label, randomised, two-treatment, two-period, two-sequence, single dose, cross-over bioequivalence study of Doxorubicin Hydrochloride (Pegylated liposomal) concentrate for solution for infusion 20 mg/10mL (2 mg/ml) of Dr. Reddy’s Laboratories Ltd, India, with that of Caelyx® 2 mg/mL [Doxorubicin Hydrochloride (Pegylated Liposomal) concentrate for solution for infusion (20 mg/10mL)] of Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Belgium in advanced ovarian cancer and/or metastatic breast cancer patients under fed condition.

Duration: 2 Years

Status: Closed

Study Title: A prospective, multicentre, randomised, double blind, Phase III study to compare the efficacy and safety of Biosimilar Bevacizumab of Enzene Biosciences Ltd. versus Innovator Bevacizumab both in Combination with CAPEOX in Patients with Metastatic Colorectal Cancer

Duration: 1 Year 4 Months

Status: Closed

Study Title: Infosys Foundation’s Community Engagement Model for Maternal & Child Health

Status: Ongoing

Study Title: Addressing Water Scarcity and Hunger in Tribal Population - Soygaon Taluka, Maharashtra

Status: Closed